Biocartis Group N.V.
BIOGF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.02 | 0.00 | 0.00 |
| FCF Yield | -52.13% | -55.66% | -17,142.25% | -15.25% |
| EV / EBITDA | -8,163.72 | -6,072.85 | 0.00 | -12.54 |
| Quality | ||||
| ROIC | -0.02% | -0.02% | 0.00% | -25.87% |
| Gross Margin | -6.25% | -9.09% | 48.19% | 29.72% |
| Cash Conversion Ratio | 0.94 | 0.57 | 0.69 | 0.92 |
| Growth | ||||
| Revenue 3-Year CAGR | 63.38% | 4,728,799.95% | 5,030,153.85% | 4,504,372.92% |
| Free Cash Flow Growth | -34.83% | 99.95% | -34.65% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -8,160.10 | -6,070.40 | 0.00 | -3.88 |
| Interest Coverage | 0.00 | 0.00 | -4.20 | -6.72 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 1.05 |
| Cash Conversion Cycle | 96,177.08 | 70,445.55 | 0.00 | 86.65 |